Results of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Trial by Stroke Subtypes - Concepedia

Concepedia

Publication | Closed Access

Results of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Trial by Stroke Subtypes

264

Citations

13

References

2009

Year

Pierre Amarenco, Oscar Benavente, Larry B. Goldstein, Alfred Callahan, Henrik Sillesen, Michael G. Hennerici, Steve Gilbert, Amy E. Rudolph, Lisa Simunovic, Justin A. Zivin,

Abstract

Atorvastatin 80 mg/d is similarly efficacious in preventing strokes and other cardiovascular events, irrespective of baseline ischemic stroke subtype.

References

	Year	Citations

Page 1